Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schrader

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The Journal of Investigative Dermatology|September 21, 2024
Deep Learning-Based Classification of Early-Stage Mycosis Fungoides and Benign Inflammatory Dermatoses on H&E-Stained Whole-Slide Images: A Retrospective, Proof-of-Concept StudyThom Doeleman, Siemen Brussee, Liesbeth M Hondelink, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysisLiesbeth M Hondelink, Anne M R Schrader, Golzar Asri Aghmuni, et al.
The American Journal of Surgical Pathology|June 13, 2025
IgM Immunohistochemical Expression is a Potential Risk Factor for Extracutaneous Dissemination in Patients With Primary Cutaneous Follicle Center LymphomaAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
HIV Clinical Trials|October 9, 2001
Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trialJ P Lalezari, J A Beal, P J Ruane, et al.
Ebiomedicine|March 19, 2025
Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumoursChiel F Ebbelaar, Anne M L Jansen, Leonie C M Speet, et al.
Virchows Archiv : an International Journal of Pathology|January 14, 2022
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomasAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
Haematologica|May 25, 2019
<i>MYD88</i> mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosisJoost S Vermaat, Sebastiaan F Somers, Liesbeth C de Wreede, et al.
AIDS (London, England)|April 7, 2007
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis, Jeffrey P Nadler, Daniel S Berger, et al.
Cancers|October 27, 2022
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease MonitoringAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2024
Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanomaIsabella A J van Duin, Mark Schuiveling, Laurens S Ter Maat, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Investigative Dermatology|September 21, 2024
Deep Learning-Based Classification of Early-Stage Mycosis Fungoides and Benign Inflammatory Dermatoses on H&E-Stained Whole-Slide Images: A Retrospective, Proof-of-Concept StudyThom Doeleman, Siemen Brussee, Liesbeth M Hondelink, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysisLiesbeth M Hondelink, Anne M R Schrader, Golzar Asri Aghmuni, et al.
The American Journal of Surgical Pathology|June 13, 2025
IgM Immunohistochemical Expression is a Potential Risk Factor for Extracutaneous Dissemination in Patients With Primary Cutaneous Follicle Center LymphomaAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
HIV Clinical Trials|October 9, 2001
Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trialJ P Lalezari, J A Beal, P J Ruane, et al.
Ebiomedicine|March 19, 2025
Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumoursChiel F Ebbelaar, Anne M L Jansen, Leonie C M Speet, et al.
Virchows Archiv : an International Journal of Pathology|January 14, 2022
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomasAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
Haematologica|May 25, 2019
<i>MYD88</i> mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosisJoost S Vermaat, Sebastiaan F Somers, Liesbeth C de Wreede, et al.
AIDS (London, England)|April 7, 2007
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis, Jeffrey P Nadler, Daniel S Berger, et al.
Cancers|October 27, 2022
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease MonitoringAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2024
Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanomaIsabella A J van Duin, Mark Schuiveling, Laurens S Ter Maat, et al.
Pageof 8